Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial
But that quality promise can only be fulfilled if it's met with equally meticulous handling on your end
Remove The Fat That You Can't Lose
West Family Memorial Fund, Inagene and Timeposters Fellowship and industry funding for speaker/consultation/research fees from iGan, Boehringer Ingelheim, Abbvie, Braxia Health (Canadian Rapid Treatment Centre of Excellence), Braxia Scientific, Janssen, Allergan, Lundbeck, Sunovion and COMPASS
Cardiovascular diseases are the leading cause of death globally, taking an estimated $17.9 million lives each year, and in the U.S., nearly one-half of all Americans suffer from some form of cardiovascular disease
Some of our most exciting research at Encore Research Group is for these new cholesterol lowering medications such as PCSK9 inhibitors
